Onkoloogia (pediaatria)

Individuaalne/modifitseeritud keemiaravi (annuse kohandamine või edasilükkamine)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (avab uue akna)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Allikas‎: N Engl J Med 1998;338(8):499-505.

Indekseeritud‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (avab uue akna)

Childhood cancer and the Jehovah's Witness faith. (avab uue akna)

Frankel LS, Damme CJ, Eys JV.

Allikas‎: Pediatrics 1977;60(6):916-21.

Indekseeritud‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (avab uue akna)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (avab uue akna)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Allikas‎: J Clin Oncol 2004;22(24):4888-92.

Indekseeritud‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (avab uue akna)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (avab uue akna)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Allikas‎: JAMA Oncol 2022;8(1):79-87. 

Indekseeritud‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (avab uue akna)

Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. (avab uue akna)

LeBlanc FR, Breese EH, Burns KC, Chang EK, Jones LM, Lee L, Mizukawa B, Norris RE, O'Brien MM, Phillips CL, Perentesis JP, Rubinstein J, Pommert L

Allikas‎: Br J Haematol 2024;205(3):1055-66.

Indekseeritud‎: PubMed 39082439

DOI‎: 10.1111/bjh.19679

https://pubmed.ncbi.nlm.nih.gov/39082439/ (avab uue akna)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (avab uue akna)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Allikas‎: Haematologica 2000;85(11):1221-2.

Indekseeritud‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (avab uue akna)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (avab uue akna)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Allikas‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indekseeritud‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (avab uue akna)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (avab uue akna)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Allikas‎: Bone Marrow Transplant 2003;32(4):433-6.

Indekseeritud‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (avab uue akna)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (avab uue akna)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Allikas‎: Bone Marrow Transplant 2005;36(8):715-20.

Indekseeritud‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (avab uue akna)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (avab uue akna)

Zwaan CM, Kaspers GJ

Allikas‎: Br J Haematol 2004;127(3):264-79.

Indekseeritud‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (avab uue akna)